Feasibility, acceptability and preliminary effectiveness of patient advocates for improving asthma outcomes in adults

Abstract Background: Asthmatic adults from low-income urban neighborhoods have inferior health outcomes which in part may be due to barriers accessing care and with patient-provider communication. We adapted a patient advocate (PA) intervention to overcome these barriers. Objective: To conduct a pilot study to assess feasibility, acceptability and preliminary evidence of effectiveness. Methods: A prospective randomized design was employed with mixed methods evaluation. Adults with moderate or severe asthma were randomized to 16 weeks of PA or a minimal intervention (MI) comparison condition. The PA, a non-professional, modeled preparations for a medical visit, attended the visit and confirmed understanding. The PA facilitated scheduling, obtaining insurance coverage and overcoming barriers to implementing medical advice. Outcomes included electronically-monitored inhaled corticosteroid (ICS) adherence, asthma control, quality of life, FEV1, emergency department (ED) visits and hospitalizations. Mixed-effects models guided an intention-to-treat analysis. Results: 100 adults participated: age 47 ± 14 years, 75% female, 71% African–American, 16% white, baseline FEV1 69% ± 18%, 36% experiencing hospitalizations and 56% ED visits for asthma in the prior year. Ninety-three subjects completed all visits; 36 of 53 PA-assigned had a PA visit. Adherence declined significantly in the control (p = 0.001) but not significantly in the PA group (p = 0.30). Both PA and MI groups demonstrated improved asthma control (p = 0.01 in both) and quality of life (p = 0.001, p = 0.004). Hospitalizations and ED visits for asthma did not differ between groups. The observed changes over time tended to favor the PA group, but this study was underpowered to detect differences between groups. Conclusion: The PA intervention was feasible and acceptable and demonstrated potential for improving asthma control and quality of life.

[1]  L. Akinbami,et al.  Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. , 2012, NCHS data brief.

[2]  C. Rand,et al.  Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial. , 2011, The Journal of allergy and clinical immunology.

[3]  L. Akinbami,et al.  Asthma prevalence, health care use, and mortality: United States, 2005-2009. , 2011, National health statistics reports.

[4]  A. Apter,et al.  Clearing Clinical Barriers: Enhancing Social Support Using a Patient Navigator for Asthma Care , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

[5]  M. Pladevall,et al.  A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. , 2010, The Journal of allergy and clinical immunology.

[6]  M. Dimatteo,et al.  Physician Communication and Patient Adherence to Treatment : A Meta-analysis , 2018 .

[7]  C. Rand,et al.  Addressing asthma health disparities: a multilevel challenge. , 2009, The Journal of allergy and clinical immunology.

[8]  Jennifer Schore,et al.  Effects of care coordination on hospitalization, quality of care, and health care expenditures among Medicare beneficiaries: 15 randomized trials. , 2009, JAMA.

[9]  Stephen A. Martin,et al.  A Reengineered Hospital Discharge Program to Decrease Rehospitalization , 2009, Annals of Internal Medicine.

[10]  J. Mandelblatt,et al.  Patient navigation: State of the art or is it science? , 2008, Cancer.

[11]  H. Dean,et al.  Evaluation of a Systems Navigator Model for Transition From Pediatric to Adult Care for Young Adults With Type 1 Diabetes , 2008, Diabetes Care.

[12]  D. Roter,et al.  Hidden in plain sight: medical visit companions as a resource for vulnerable older adults. , 2008, Archives of internal medicine.

[13]  C. Fang,et al.  A Multifaceted Intervention to Increase Cervical Cancer Screening among Underserved Korean Women , 2007, Cancer Epidemiology Biomarkers & Prevention.

[14]  K. Ell,et al.  Best Practice Case Management for Improved Medical Adherence , 2007, Social work in health care.

[15]  J. Ellis,et al.  Increasing Utilization of Cancer Genetic Counseling Services Using a Patient Navigator Model , 2007, Journal of Genetic Counseling.

[16]  Linda Abetz,et al.  Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. , 2006, Respiratory medicine.

[17]  D. Vlahov,et al.  Evaluation of an Intervention to Increase Screening Colonoscopy in an Urban Public Hospital Setting , 2006, Journal of Urban Health.

[18]  J. Celedón,et al.  Asthma in Hispanics. , 2006, American journal of respiratory and critical care medicine.

[19]  H. Freeman,et al.  Determinants of cancer disparities: barriers to cancer screening, diagnosis, and treatment. , 2005, Surgical oncology clinics of North America.

[20]  D. Schrag,et al.  Using navigators to improve care of underserved patients , 2005, Cancer.

[21]  M. Joffe,et al.  Influences of earlier adherence and symptoms on current symptoms: a marginal structural models analysis. , 2005, The Journal of allergy and clinical immunology.

[22]  Daniel Bogen,et al.  Adherence logger for a dry powder inhaler: a new device for medical adherence research. , 2004, The Journal of allergy and clinical immunology.

[23]  H. Freeman.  A Model Patient Navigation Program , 2004 .

[24]  Paula Lozano,et al.  Cultural competence policies and other predictors of asthma care quality for Medicaid-insured children. , 2004, Pediatrics.

[25]  Harold I Feldman,et al.  Modifiable barriers to adherence to inhaled steroids among adults with asthma: it's not just black and white. , 2003, The Journal of allergy and clinical immunology.

[26]  R. Zuwallack,et al.  Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[27]  J. Coyne,et al.  Research to improve the quality of care for depression: alternatives to the simple randomized clinical trial. , 2003, General hospital psychiatry.

[28]  Kevin B Weiss,et al.  The cost-effectiveness of an inner-city asthma intervention for children. , 2002, The Journal of allergy and clinical immunology.

[29]  E. Juniper,et al.  Measuring asthma control in group studies: do we need airway calibre and rescue beta2-agonist use? , 2001, Respiratory medicine.

[30]  C. Rand,et al.  Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[31]  E. Juniper,et al.  Measuring asthma control. Clinic questionnaire or daily diary? , 2000, American journal of respiratory and critical care medicine.

[32]  N. Nagelkerke,et al.  Estimating treatment effects in randomized clinical trials in the presence of non-compliance. , 2000, Statistics in medicine.

[33]  G H Guyatt,et al.  Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.

[34]  P. Gergen,et al.  A randomized clinical trial to reduce asthma morbidity among inner-city children: results of the National Cooperative Inner-City Asthma Study. , 1999, The Journal of pediatrics.

[35]  G. Guyatt,et al.  Development and validation of the Mini Asthma Quality of Life Questionnaire. , 1999, The European respiratory journal.

[36]  A. Buist,et al.  Validation of a standardized version of the Asthma Quality of Life Questionnaire. , 1999, Chest.

[37]  R. Zuwallack,et al.  Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. , 1998, American journal of respiratory and critical care medicine.

[38]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[39]  C. Rand,et al.  Noncompliance and treatment failure in children with asthma. , 1996, The Journal of allergy and clinical immunology.

[40]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[41]  G. Cochrane,et al.  The psychological factors associated with poor compliance with treatment in asthma. , 1995, The European respiratory journal.

[42]  C. Rand,et al.  Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. , 1993, Chest.

[43]  C. Rand,et al.  Metered-dose inhaler adherence in a clinical trial. , 1992, The American review of respiratory disease.

[44]  W. Bailey,et al.  Medication adherence patterns in chronic obstructive pulmonary disease. , 1991, Chest.

[45]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[46]  C. Rand,et al.  Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial. , 2012, The Journal of allergy and clinical immunology.

[47]  H. Freeman.  Patient navigation: a community centered approach to reducing cancer mortality. , 2006, Journal of cancer education : the official journal of the American Association for Cancer Education.

[48]  Adrienne Y. Stith,et al.  Unequal treatment: confronting racial and ethnic disparities in health care. , 2003 .

[49]  N. Leidy,et al.  Is the asthma quality of life questionnaire a useful measure for low-income asthmatics? , 1998, American journal of respiratory and critical care medicine.

[50]  G H Guyatt,et al.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.

[51]  Rascon.  [The National Cancer Institute]. , 1953, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.